Top Stories

For heart health, you're supposed to know your numbers: total cholesterol, the bad LDL kind and the good HDL kind.   Associated Press - November 7, 2011

Section:

0
No votes yet

On Friday, May 3, the U.S. FDA approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein (LDL) cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough. For more information, please... more

Section:

0
No votes yet

The window for nominations to NLA and Chapter leadership positions is now open through February 28, 2021. Open positions include:  National Lipid Association positions include: At-Large Board Member (up to 7) Chapter positions include: President-Elect Treasurer... more

Section:

0
No votes yet

All U.S. children between the ages of 9 and 11 should be screened for high cholesterol, according to new guidelines endorsed by the nation's leading group of pediatricians.   U.S. News & World Report - November 11, 2011

Section:

0
No votes yet

The National Lipid Association (NLA) has named Matthew Ito, PharmD (’86), as its new president. Membership of the NLA includes physicians, pharmacists, researchers, nurses, physician assistants and dietitians.   USC School of Pharmacy News – June 2013

Section:

0
No votes yet

Responses from healthcare workers show significant barriers to prescriptions PCSK9 Inhibitors Survey Findings Infographic Download PCSK9 Inhibitors Approval Checklist Download JACKSONVILLE, Fla. — The National Lipid Association (NLA) released on Wednesday the results of its survey on... more

Section:

0
No votes yet

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more

Section:

0
No votes yet

Further results from the two phase 3 trials of the omega-3 fatty acid product ethyl eicosapentaenoic acid (EPA) (AMR101, Amarin), which showed the agent reduced triglycerides without increasing low-density lipoprotein (LDL) and reduced the number of atherogenic particles, were presented last week... more

Section:

0
No votes yet

Amit Khera, M.D., Saskia Neher, Ph.D., each earn two-year grant for lipid disorder research NLA Junior Faculty Research Award Information JACKSONVILLE, Fla. — The National Lipid Association (NLA) announced on Thursday the recipients of its inaugural Junior Faculty Research Awards for... more

Section:

0
No votes yet

Novartis announced that the U.S. Food and Drug Administration (FDA) approved Leqvio (inclisiran) as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH... more

Section:

0
No votes yet